DexCom, Inc. (DXCM)
73.80
+0.37
(+0.50%)
USD |
NASDAQ |
Mar 02, 16:00
73.48
-0.32
(-0.43%)
After-Hours: 17:30
DexCom Research and Development Expense (Annual) : 594.90M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| BioLife Solutions, Inc. | 7.566M |
| Abbott Laboratories | 2.889B |
| Insulet Corp. | 301.10M |
| Krystal Biotech, Inc. | 52.32M |
| Boston Scientific Corp. | 2.052B |